These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23297371)

  • 1. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.
    Messaoudi S; Gravez B; Tarjus A; Pelloux V; Ouvrard-Pascaud A; Delcayre C; Samuel J; Launay JM; Sierra-Ramos C; Alvarez de la Rosa D; Clément K; Farman N; Jaisser F
    Hypertension; 2013 Feb; 61(2):361-7. PubMed ID: 23297371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
    Lavall D; Selzer C; Schuster P; Lenski M; Adam O; Schäfers HJ; Böhm M; Laufs U
    J Biol Chem; 2014 Mar; 289(10):6656-6668. PubMed ID: 24469458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
    Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
    Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.
    Gravez B; Tarjus A; Jimenez-Canino R; El Moghrabi S; Messaoudi S; Alvarez de la Rosa D; Jaisser F
    PLoS One; 2013; 8(9):e73737. PubMed ID: 24040049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.
    Ayuzawa N; Nagase M; Ueda K; Nishimoto M; Kawarazaki W; Marumo T; Aiba A; Sakurai T; Shindo T; Fujita T
    Hypertension; 2016 Jan; 67(1):99-106. PubMed ID: 26527051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor overexpression in embryonic stem cell-derived cardiomyocytes increases their beating frequency.
    Le Menuet D; Munier M; Meduri G; Viengchareun S; Lombès M
    Cardiovasc Res; 2010 Aug; 87(3):467-75. PubMed ID: 20299331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes.
    Lee YS; Kim JA; Kim KL; Jang HS; Kim JM; Lee JY; Shin IS; Lee JS; Suh W; Choi JH; Jeon ES; Byun J; Kim DK
    J Korean Med Sci; 2004 Dec; 19(6):805-11. PubMed ID: 15608389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.
    Qin W; Rudolph AE; Bond BR; Rocha R; Blomme EA; Goellner JJ; Funder JW; McMahon EG
    Circ Res; 2003 Jul; 93(1):69-76. PubMed ID: 12791709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes.
    Rossier MF; Python M; Maturana AD
    Endocrinology; 2010 Jun; 151(6):2777-87. PubMed ID: 20392829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?
    Hermidorff MM; Faria Gde O; Amâncio Gde C; de Assis LV; Isoldi MC
    Biochem Cell Biol; 2015 Feb; 93(1):83-93. PubMed ID: 25488178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Activation of the Alternative Cardiac Promoter of
    Mesquita TR; Auguste G; Falcón D; Ruiz-Hurtado G; Salazar-Enciso R; Sabourin J; Lefebvre F; Viengchareun S; Kobeissy H; Lechène P; Nicolas V; Fernandez-Celis A; Gómez S; Lauton Santos S; Morel E; Rueda A; López-Andrés N; Gómez AM; Lombès M; Benitah JP
    Circ Res; 2018 Mar; 122(7):e49-e61. PubMed ID: 29467196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling?
    Fejes-Tóth G; Náray-Fejes-Tóth A
    Endocrinology; 2007 Apr; 148(4):1502-10. PubMed ID: 17234708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.
    Lavall D; Schuster P; Jacobs N; Kazakov A; Böhm M; Laufs U
    J Biol Chem; 2017 May; 292(18):7542-7553. PubMed ID: 28320863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone-induced changes in the cardiac L-type Ca(2+) current can be prevented by antioxidants in vitro and are absent in rats on low salt diet.
    Wagner M; Rudakova E; Volk T
    Pflugers Arch; 2008 Nov; 457(2):339-49. PubMed ID: 18504604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
    Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart.
    Latouche C; Sainte-Marie Y; Steenman M; Castro Chaves P; Naray-Fejes-Toth A; Fejes-Toth G; Farman N; Jaisser F
    Endocrinology; 2010 Sep; 151(9):4467-76. PubMed ID: 20591974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.
    Ohtani T; Ohta M; Yamamoto K; Mano T; Sakata Y; Nishio M; Takeda Y; Yoshida J; Miwa T; Okamoto M; Masuyama T; Nonaka Y; Hori M
    Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R946-54. PubMed ID: 17023667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.